UK markets open in 4 hours 47 minutes

Intra-Cellular Therapies, Inc. (ITCI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
70.34-2.39 (-3.29%)
At close: 04:00PM EDT
70.02 -0.32 (-0.45%)
After hours: 05:45PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts14141514
Avg. Estimate-0.32-0.2-0.641.08
Low estimate-0.47-0.32-1-0.46
High estimate-0.24-0.14-0.293.14
Year ago EPS-0.46-0.45-1.46-0.64
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts13131515
Avg. Estimate141.38M159.37M662.06M921.37M
Low estimate136.91M155.58M652M792M
High estimate145.1M165.4M681.1M1.05B
Year ago sales91.98M110.79M464.37M662.06M
Sales growth (year/est)53.70%43.80%42.60%39.20%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.61-0.59-0.57-0.44
Actual EPS-0.46-0.45-0.25-0.3
Difference0.150.140.320.14
Surprise %24.60%23.70%56.10%31.80%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.32-0.2-0.641.08
7 days ago-0.32-0.2-0.641.08
30 days ago-0.33-0.21-0.671.28
60 days ago-0.32-0.22-0.691.15
90 days ago-0.31-0.22-0.531.55
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 days166N/A
Up last 30 days7895
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/A1
Growth estimatesITCIIndustrySector(s)S&P 500
Current qtr.30.40%N/AN/AN/A
Next qtr.55.60%N/AN/AN/A
Current year56.20%N/AN/AN/A
Next year268.80%N/AN/AN/A
Next 5 years (per annum)291.40%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A